x
- Home
- About Diabetes
- Services
- Diabetes Mellitus Modeling Solutions
- R&D Services for Diabetes Mellitus and Diabetic Complications
- By Drug Development Process
- About Us
- Careers
- Contact Us
Cat. No.: DMM-001132
| Status | Age | Sex |
|---|---|---|
|
|
|
| Product Overview | |
|---|---|
| Model Description | These Hnf4a flox mice possess loxP sites flanking exon 2. When crossed with a Cre recombinase-expressing strain, this strain is useful in eliminating tissue-specific conditional expression of the gene. |
| Strain Name | C57BL/6J-Hnf4atm1(flox) |
| Background Strain | C57BL/6J |
| SPF | Yes |
| Research Application | Transcriptional regulator; insulin secretion related. |
| Target Information | |
|---|---|
| Target Name | Hnf4a |
| Synonyms | Hnf4, HNF-4, MODY1, Nr2a1, Tcf14, TCF-14, Hnf4alpha |
| Gene ID | 15378 |
Ace Therapeutics has a team of wellknown experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.
